VOMERO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 6.254
EU - Europa 4.928
AS - Asia 2.519
SA - Sud America 481
AF - Africa 58
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 6
Totale 14.253
Nazione #
US - Stati Uniti d'America 6.193
GB - Regno Unito 1.300
CN - Cina 1.109
RU - Federazione Russa 836
SG - Singapore 733
IE - Irlanda 670
UA - Ucraina 487
DE - Germania 472
SE - Svezia 464
BR - Brasile 411
FR - Francia 253
IT - Italia 194
HK - Hong Kong 189
KR - Corea 177
FI - Finlandia 134
VN - Vietnam 104
IN - India 70
ES - Italia 36
TR - Turchia 35
AR - Argentina 29
CA - Canada 28
CI - Costa d'Avorio 25
MX - Messico 20
ID - Indonesia 16
BD - Bangladesh 15
EC - Ecuador 14
BE - Belgio 12
CZ - Repubblica Ceca 12
ZA - Sudafrica 12
IQ - Iraq 11
PL - Polonia 10
JP - Giappone 9
CO - Colombia 8
AZ - Azerbaigian 7
NL - Olanda 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
AT - Austria 6
EE - Estonia 6
EU - Europa 6
PY - Paraguay 6
CL - Cile 5
LT - Lituania 5
MA - Marocco 5
NG - Nigeria 5
PK - Pakistan 5
CR - Costa Rica 4
NZ - Nuova Zelanda 4
PH - Filippine 4
UZ - Uzbekistan 4
AU - Australia 3
EG - Egitto 3
JO - Giordania 3
SA - Arabia Saudita 3
VE - Venezuela 3
AL - Albania 2
CH - Svizzera 2
DO - Repubblica Dominicana 2
HN - Honduras 2
HU - Ungheria 2
KE - Kenya 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LK - Sri Lanka 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PT - Portogallo 2
TH - Thailandia 2
UY - Uruguay 2
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BO - Bolivia 1
BW - Botswana 1
CV - Capo Verde 1
DK - Danimarca 1
DZ - Algeria 1
GT - Guatemala 1
HR - Croazia 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
TN - Tunisia 1
Totale 14.253
Città #
Southend 1.171
Fairfield 816
Dallas 783
Dublin 668
Ashburn 432
Singapore 430
Jacksonville 403
Woodbridge 357
Chandler 349
Santa Clara 333
Wilmington 318
Seattle 285
Cambridge 269
Beijing 251
Houston 243
Moscow 231
Ann Arbor 188
Hong Kong 188
Hefei 187
Seoul 176
Princeton 156
Nanjing 136
Siena 87
Los Angeles 70
Fremont 67
Boardman 63
Nanchang 49
Shenyang 46
Helsinki 44
Buffalo 42
Munich 42
San Diego 40
Bengaluru 38
New York 37
Shanghai 37
Dearborn 36
Ho Chi Minh City 36
São Paulo 33
Lancaster 32
Düsseldorf 28
Hebei 28
Málaga 28
Abidjan 25
Hanoi 25
Tianjin 25
Izmir 22
Menlo Park 22
Norwalk 22
San Mateo 22
Jiaxing 20
Jinan 20
Changsha 18
Kunming 18
San Francisco 18
Venezia 18
Mestre 17
Redwood City 16
London 15
Washington 15
Philadelphia 14
Stockholm 14
Zhengzhou 14
Frankfurt am Main 13
Rio de Janeiro 13
The Dalles 12
Belo Horizonte 11
Brussels 11
Turku 10
Toronto 9
Atlanta 8
Curitiba 8
Ningbo 8
Brasília 7
Brno 7
Brooklyn 7
Milan 7
Montreal 7
Redondo Beach 7
Ribeirão Preto 7
Tokyo 7
Ankara 6
Baku 6
Biên Hòa 6
Boston 6
Chicago 6
Fuzhou 6
Guangzhou 6
Guarulhos 6
Hangzhou 6
Lanzhou 6
Leawood 6
Orem 6
Ottawa 6
Quito 6
Tallinn 6
Vienna 6
Campinas 5
Fortaleza 5
Gdynia 5
Guayaquil 5
Totale 9.908
Nome #
Design, Synthesis, and Biological Evaluation of Imidazo[1,5-a]quinoline as Highly Potent Ligands of Central Benzodiazepine Receptors 352
Anionic Polymerization of a Benzofulvene Monomer Leading to a Thermoreversible π-Stacked Polymer. Studies in Macromolecular and Aggregate Structure 321
A Click Chemistry-Based “Grafting Through” Approach to the Synthesis of a Biorelevant Polymer Brush 312
A Nanocomposite Material Formed by Benzofulvene Polymer Nanoparticles Loaded with a Potent 5-HT3 Receptor Antagonist (CR3124) 297
A Non-Peptide NK1 Receptor Agonist Showing Subpicomolar Affinity 271
Combining Spontaneous Polymerization and Click Reactions for the Synthesis of Polymer Brushes: A “Grafting Onto” Approach 243
Characterization of persistent intramolecular C-H⋅⋅⋅X(N,O) bonds in solid state and solution 230
Synthesis and Spontaneous Polymerization of Oligo(ethylene glycol)-Conjugated Benzofulvene Macromonomers. A Polymer Brush Forming a Physical Hydrogel 230
Bivalent Ligands for the Serotonin 5-HT3 Receptor 228
Characterization of Quinoline Derivatives. II. 7-(4-methyl-1-piperazinyl)-6H-[1]benzopyrano[3,4-c]quinoline 226
Novel Analgesic/Anti-inflammatory Agents: 1,5-Diarylpyrrole Nitrooxyalkyl Ethers and Related Compounds as Cyclooxygenase-2 Inhibiting Nitric Oxide Donors 219
5-HT and Benzodiazepine Receptor Ligands. III. Synthesis and Receptor Affinities of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline and 2,3-Dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinoline-1-one Derivatives 216
The Interactions of the 5-HT3 Receptor with Quipazine-Like Arylpiperazine Ligands. The Journey Track at the End of the First Decade of the Third Millennium 215
Physicochemical and biopharmaceutical characterization of endo-2-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-2,3-dihydro-1H-benz[e]isoindol-1-one (CR3124) a novel potent 5-HT3 receptor antagonist 213
Design, Synthesis, and Structure-Affinity Relationship Studies in NK1 Receptor Ligands Based on Azole-Fused Quinolinecarboxamide Moieties 212
Design, Synthesis, and Biological Evaluation of AT1 Angiotensin II Receptor Antagonists Based on the Pyrazolo[3,4-b]pyridine and related Heteroaromatic Bicyclic Systems 208
Amidine, Thiourea and Guanidine Derivatives of 2-Aminobenzothiazoles and Aminobenzothiazines, Novel Pharmacological Agents for the Treatment of Neurodegenerative Pathologies 207
6-(1-Piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives with High Affinity and Selectivity for 5-HT3 Serotonin Sites 205
Design, Synthesis, and Preliminary Biological Evaluation of Pyrrolo[3,4-c]quinolin-1-one and Oxoisoindoline Derivatives as Aggrecanase Inhibitors 204
Phenylindenone isomers as divergent modulators of p38α MAP kinase 201
Characterization of Quinoline Derivatives. I. 6,7-Dihydro-8-(4-methyl-1-piperazinyl)[1]benzoxepino[4,5-c]quinoline 0.13-Hydrate 199
Structural Manipulation of Benzofulvene Derivatives Showing Spontaneous Thermoreversible Polymerization. Role of the Substituents in the Modulation of Polymer Properties 196
11C-Labelling of the 5-HT3 Antagonist VC125 for PET Distribution Studies 191
Synthesis and characterization of charge-transporting π-stacked polybenzofulvene derivatives 189
Reversible polymerization techniques leading to π-stacked polymers 183
Synthesis and biological evaluation of amidine, guanidine, and thiourea derivatives of 2-amino(6-trifluoromethoxy)benzothiazole as neuroprotective agents potentially useful in brain diseases 182
Synthesis of 2-Substituted-2,3-dihydro-9-phenyl-1H-pyrrolo[3,4-b]quinolin-3-ones as Potential Peripheral Benzodiazepine-receptor Ligands 181
Synthesis of 6,7-Dihydro-8-(4-methyl-1-piperazinyl)-[1]benzoxepino[4,5-c]quinoline as Potential 5-HT3 Receptor Ligand 178
Synthesis and Structure-Activity Relationship Studies in Translocator Protein Ligands Based on a Pyrazolo[3,4-b]quinoline Scaffold 178
Synthesis, Biological Evaluation, and Quantitative Receptor Docking Simulations of 2-Acylaminoethyl-1,4-benzodiazepines as novel Tifluadom-Like Ligands with High Affinity and Selectivity for k-Opioid Receptors 178
Heterotricyclic Amide Derivatives as Neurokinin-1 (NK1) Receptor Ligands 176
Synthesis of 6-(4-Methyl-1-piperazinyl)-7H-indeno[2,1-c]quinoline Derivatives as Potential 5-HT Receptor Ligands 176
Synthesis of 1,2,4,-Triazolo[4',3':1,6]pyridazino[4,5-b]quinoline Derivatives 176
Structure-Activity Relationships in Carboxamide Derivatives Based on the Targeted Delivery of Radionuclides and Boron Atoms by Means of Peripheral Benzodiazepine Receptor Ligands 175
Mapping and Fitting the Peripheral Benzodiazepine Receptor Binding Site by Carboxamide Derivatives. Comparison of Different Approaches to Quantitative Ligand-Receptor Interaction Modeling 173
Non-peptide NK1 receptor ligands based on the 4-phenylpyridine moiety 173
Further studies on imidazo[4,5-b]pyridine AT1 angiotensin II receptor antagonists. Effects of the transformation of the 4-phenylquinoline backbone into 4-phenylisoquinolinone or 1-phenylindene scaffolds 172
New red-shifted coelenterazine analogues with an extended electronic conjugation 171
Mapping the Peripheral Benzodiazepine Receptor Binding Site by Conformationally Restrained Derivatives of 1-(2-Chlorophenyl)-N-methyl-N-(1-methylpropyl)-3-isoquinolinecarboxamide (PK11195) 169
Structure-Property Relationships in Densely Grafted π-Stacked Polymers 169
null 169
Novel and Highly Potent 5-HT3 Receptor Agonists Based on a Pyrroloquinoxaline Structure 168
Synthesis and Characterization of a New Benzofulvene Polymer Showing a Thermoreversible Polymerization Behavior 167
Molecular Basis of Peripheral vs Central Benzodiazepine Receptor Selectivity in a New Class of Peripheral Benzodiazepine Receptor Ligands Related to Alpidem 167
Synthesis, Labeling, and Biological Evaluation of Halogenated 2-Quinolinecarboxamides as Potential Radioligands for the Visualization of Peripheral Benzodiazepine Receptors 165
Novel Basic Derivatives of Benz[e]isoindol-1-ones and Pyrrolo[3,4-c]quinolin-1-ones with 5-HT3 Antagonistic Activity, their Preparation and their Therapeutic Use 165
Multivalent Supramolecular Dendrimer-Based Drugs 164
Determination of a novel angiotensin-AT1 Antagonist CR3210, in biological samples by HPLC 163
Characterization and Differentiation of Heterocyclic Isomers. Part 2. Mass Spectrometry and Molecular Orbital Calculations on Pyrrolo[1,2-a][1,4]benzodiazepin-4-one, -6-one, -4,6-dione 163
New Insight into the Central Benzodiazepine Receptor-Ligand Interactions: Design, Synthesis, Biological Evaluation, and Molecular Modeling of 3-Substituted 6-Phenyl-4H-imidazo[1,5-a][1,4]benzodiazepines and Related Compounds 159
Ethyl 8-Fluoro-6-(3-nitrophenyl)-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate as Novel, Highly Potent, and Safe Antianxiety Agent 157
Characterization of Quinoline Derivatives. Part 3. Mass Spectrometry and X-ray Crystallography of Biologically Interesting Arylquinolines 155
Further Studies on the Interaction of 5-Hydroxytryptamine3 (5-HT3) Receptor with Arylpiperazine Ligands. Development of a New 5-HT3 Receptor Ligand Showing Potent Acetylcholinesterase Inhibitory Properties 154
Hyaluronan derivatives bearing variable densities of ferulic acid residues 154
Molecular Structure and Dynamics of Some Potent 5-HT3 Receptor Antagonists. Insight into the Interaction with the Receptor 152
Design, Synthesis, Structural Studies, Biological Evaluation, and Computational Simulations of Novel Potent AT1 Angiotensin II Receptor Antagonists Based on the 4-Phenylquinoline Structure 152
CoMFA Analysis of Ligands of the Mitochondrial Benzodiazepine Receptor: A Versatile Tool for the Design of New Lead Compounds 150
Synthesis and Biological Characterization of Novel 2-Quinolinecarboxamide Ligands of the Peripheral Benzodiazepine Receptors Bearing Technetium-99m or Rhenium 149
Synthesis, Resolution, and Absolute Configuration of Two Novel and Selective Cyclooxygenase-2 Inhibitors Based on 1,5-Diarylpyrrole Structure 148
Structure–affinity relationship studies on arylpiperazine derivatives related to quipazine as serotonin transporter ligands. Molecular basis of the selectivity SERT/5-HT3 receptor 144
Synthesis and structure-activity relationship studies in peripheral benzodiazepine receptor ligands related to alpidem 142
Novel polybenzofulvene derivatives: synthesis and uses thereof 140
Novel potent 5-HT3 receptor ligands based on the pyrrolidone structure: synthesis, biological evaluation, and computational rationalization of the ligand-receptor interaction modalities 139
Novel Potent 5-HT3 Receptor Ligands Based on the Pyrrolidone Structure. Effects of the Quaternization of the Basic Nitrogen on the Interaction with 5-HT3 Receptor 138
Labeling and Evaluation of N-[11C]Methylated Quinoline-2-carboxamide as Potential Radioligands for Visualization of Peripheral Benzodiazepine Receptors 136
Evaluation of Three Quinoline-Carboxamide Derivatives as Potential Radioligands for the in Vivo PET Imaging of Neurodegeneration 136
Synthesis, Biological Evaluation and Receptor Docking Simulations of 2-[(Acylamino)ethyl]-1,4-benzodiazepines as k-Opioid Receptor Agonists Endowed with Antinociceptive and Antiamnestic Activity 135
Novel Potent and Selective Central 5-HT3 Receptor Ligands Provided with Different Intrinsic Efficacy. 2. Molecular Basis of the Intrinsic Efficacy of Arylpiperazine Derivatives at the Central 5-HT3 Receptors 133
Synthesis and Benzodiazepine Receptors Affinity of 2,3-Dihydro-9- phenyl-1H-pyrrolo[3,4-b]quinolin-1-one and 3-Carbethoxy-4-phenylquinoline Derivatives 129
Novel Potent and Selective 5-HT3 Receptor Antagonists Based on Arylpiperazine Skeleton: Synthesis, Structure, Biological Activity and CoMFA Studies 127
The Interaction of the 5-HT3 Receptor with Arylpiperazine, Tropane, and Quinuclidine Ligands 126
Reversible Polymerization Techniques Leading to pi-Stacked Polymers 123
Enzymatic and Molecular Modeling Studies of 5-HT3 Receptor Ligands Based on Pyrroloquinoline Structure and Provided with Acetylcholinesterase Inhibitory Activity 121
Imidazo[1,2-a]pyrazin-3(7H)-one Derivatives Bearing a New Electron-Rich Structure. 120
π-Stacked polymers in drug delivery applications 117
Synthesis and 5-HT Receptors Binding Studies of Some 3-Substituted-2-(4-methyl-1-piperazinyl)-4-phenylquinolines 117
Synthesis of the Novel [11C]-Labelled Quinoline Carboxamides: Analogues of PK-11195 as Putative Radioligands for PET Studies of Peripheral Type Benzodiazepine Receptors 113
Synthesis of 4-Substituted-1,2,3,4-tetrahydro-11-phenyl-5H-azepino[3,4-b]quinolin-5-one as Potential Peripheral Benzodiazepine-receptor Ligands 110
Synthesis and 5-HT-Receptors Affinity of Some 4-Phenylquinoline Derivatives 110
Novel potent and selective central 5-HT3 receptor ligands provided with different intrinsic efficacy. I. Mapping the central 5-HT3 recceptor binding site by arylpiperazine derivatives 108
Synthesis and Receptor Binding Studies of 2-Functionalized 1,4-Benzodiazepine Derivatives as Potential Metaclazepam-like Antianxiety Agents 103
Synthesis of 2,10-Diphenyl-2H-pyridazino[4,5-b]quinolin-1-one and 2,3-Dihydro-9-phenyl-2-phenylamino-1H-pyrrolo[3,4-b]quinolin-1-one Derivatives as Peripheral-type Benzodiazepine Receptors Ligands 98
Totale 14.281
Categoria #
all - tutte 42.823
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.823


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021908 0 0 0 0 0 228 38 220 176 68 111 67
2021/2022997 68 151 31 174 38 14 54 25 39 104 86 213
2022/20231.420 90 108 188 210 135 296 35 106 135 36 56 25
2023/2024924 26 9 103 36 31 277 327 30 0 1 4 80
2024/20251.907 32 114 172 81 277 84 18 90 119 77 206 637
2025/20263.035 354 715 657 511 768 30 0 0 0 0 0 0
Totale 14.281